SCHEMBL4717568

SCHEMBL4717568

CCN(CC)CCNCc1ccc(-c2cc(C)cs2)cc1

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.38
USP2 O75604 1/20 0.38
HRH3 Q9Y5N1 2/20 0.38
HRH4 Q9H3N8 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.37
PDCD1 Q15116 1/20 0.36
CD274 Q9NZQ7 1/20 0.36
HDAC1 Q13547 1/20 0.36
CHRM2 P08172 1/20 0.36
HSP90AA1 P07900 1/20 0.35
KCNH2 Q12809 2/20 0.35
CCNE2 O96020 2/20 0.34
CCNA2 P20248 2/20 0.34
CCNE1 P24864 2/20 0.34
CDK2 P24941 2/20 0.34
CCNA1 P78396 2/20 0.34
S1PR1 P21453 1/20 0.34
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3457092 0.80 CHRM2 (0.51) HTTUSP2HRH3HRH4SMN1; SMN2
SCHEMBL3457044 0.75 HRH3 (0.51) HTTUSP2HRH3HRH4SMN1; SMN2
SCHEMBL3456630 0.75 HRH3 (0.45) HTTUSP2HRH3HRH4SMN1; SMN2
SCHEMBL4715354 0.75 USP2 (0.44) HTTUSP2HRH3HRH4SMN1; SMN2
SCHEMBL4713979 0.74 SMN1; SMN2 (0.53) HTTUSP2HRH3HRH4SMN1; SMN2
SCHEMBL1623822 0.73 NPC1 (0.40) SMN1; SMN2HDAC1
SCHEMBL4717200 0.73 CYP1A2 (0.53) HTTUSP2HRH3HRH4MEN1
SCHEMBL4420094 0.73 USP2 (0.60) HTTUSP2HRH3HRH4SMN1; SMN2
SCHEMBL4714093 0.73 HRH4 (0.40) HTTUSP2HRH3HRH4SMN1; SMN2
SCHEMBL3456835 0.71 HRH3 (0.44) HTTUSP2HRH3HRH4SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1337517-B1 PYRIMIDINONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF ATHEROSCLEROSIS SMITHKLINE BEECHAM PLC (GB) 2008-11-26 EP disclosed